Waltham, MA, United States of America

Barrett Katz

This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Viridian Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barrett Katz. Retrieved from https://idiyas.com/inventor/barrett-katz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Barrett Katz: Innovator in Thyroid Eye Disease Treatment

Introduction

Barrett Katz is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of medical treatments, particularly focusing on thyroid eye disease. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Barrett Katz holds a patent for "Compositions, doses, and methods for treatment of thyroid eye disease." This patent includes antibodies and compositions against IGF-1R and outlines their uses in therapeutic applications. His work in this area is crucial for advancing treatment options for patients suffering from this condition.

Career Highlights

Katz is associated with Viridian Therapeutics, Inc., where he applies his expertise to develop innovative solutions in the medical field. His role at the company allows him to collaborate with other professionals and contribute to groundbreaking research.

Collaborations

One of his notable coworkers is Denis O'Shaughnessy, with whom he collaborates on various projects aimed at improving treatment methodologies.

Conclusion

Barrett Katz's contributions to the treatment of thyroid eye disease through his patent and work at Viridian Therapeutics, Inc. highlight his commitment to medical innovation. His efforts are paving the way for better health outcomes for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…